| Title |
CD30 as a Therapeutic Target for Lymphoma
|
|---|---|
| Published in |
BioDrugs, September 2013
|
| DOI | 10.1007/s40259-013-0068-8 |
| Pubmed ID | |
| Authors |
Thomas Schirrmann, Miriam Steinwand, Xenia Wezler, Andre ten Haaf, Mehmet K. Tur, Stefan Barth |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 57 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 16% |
| Student > Ph. D. Student | 8 | 14% |
| Other | 7 | 12% |
| Student > Bachelor | 4 | 7% |
| Student > Doctoral Student | 3 | 5% |
| Other | 10 | 18% |
| Unknown | 16 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 26% |
| Biochemistry, Genetics and Molecular Biology | 9 | 16% |
| Immunology and Microbiology | 7 | 12% |
| Agricultural and Biological Sciences | 6 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
| Other | 3 | 5% |
| Unknown | 15 | 26% |